Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail)

v3.22.1
SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Jun. 03, 2020
Medtronic [Member] | Development agreement [Member]    
Disclosure Of Summary Of Significant Accounting Policies [line items]    
Total consideration   $ 31
Patents Rights [Member]    
Disclosure Of Summary Of Significant Accounting Policies [line items]    
Useful lives 20 years